Crafting Hope: The story behind NATROX® O₂ innovation
The inventor of our topical oxygen technology, Mel, had an aging aunt suffering in pain for months due to a venous leg ulcer that refused to heal. After confiding how much indescribable pain she endured, Mel wanted to find some way to help her. He knew if her wound would heal, she could be relieved of so much daily misery. And so began his quest to learn how wounds healed.
After much research, he realized oxygen was the secret to healing. He was determined to use this secret to help heal his aunt.
But how could he get oxygen near a wound without applying any pressure or chemicals to the skin? This would be key to avoid any negative side effects. Of course, he didn’t want to make things worse!
After consulting friends at the University of Cambridge, our inventor and his small team masterminded the technology today known as NATROX® O₂. This topical oxygen therapy leverages the natural properties of oxygen to stimulate healing.
In an effort to share this solution, they formed a company with a mission to develop innovative medical technology designed to help patients. Because, surely, there were people just like Mel struggling to find a solution for a hard-to-heal wounds.
Today, our mission is to transform the quality of life for anyone with a chronic wound,
because everyone deserves the chance to heal.
Hear Mel tell his story of
how it all started.
About Us
Wound Healing is Our Mission
Chronic wounds affect millions worldwide. Our mission is to transform the lives of patients suffering from hard-to-heal wounds through our innovative technology.
Passion for medicine, compassion for patients, respect among employees, and commitment to customers drives our success and enables us to restore hope to those who need it most.
An award-winning company, product, and team.
Meet the NATROX® team
Our team has a unique passion for health care and deep compassion for patients.
Get to know our team. We can help you take the next step forward in wound care.
Gordie Nye
CEO & Chairman
Gordie Nye brings a wealth of leadership experience and strategic expertise steering healthcare and technology organizations through pivotal stages of commercialization, growth and innovation. His distinguished career includes serving as CEO and Director of ZELTIQ Aesthetics, as well as Chairman and Acting Head of U.S. Operations at Atlantic Therapeutics. He currently provides leadership at several transformative companies, including serving as Chairman of the Board of Managers at Journey Biosciences, Fractional CEO & Director at INVI IVF, and Chairman of the Board at LUUM Precision Lash.
John Adam
Chief Operations Officer
John brings over 20 years of experience in medical device manufacturing having worked in multiple European and Asian countries where he delivered process and transactional improvements across manufacturing, supply chain, quality, and procurement. He is responsible for manufacturing operations, quality, and product development.
John has also worked at Molnlycke as VP of Global Manufacturing, at Systagenix (now operating as Acelity) as VP of Global Operations, and at Teleflex as Director of Strategic Development.
Specializing in Lean manufacturing, Six Sigma, Kaizen, and process improvement, colleagues across his career praise John for his strong leadership skills. He understands how to nurture individual strengths and talents, encouraging team members to think strategically, innovate, and execute.
Stefanie Brown Hawkins
Chief Financial Officer
As CFO, Stefanie oversees financial strategy and planning, ensuring the company’s fiscal health and long-term success. Stefanie has held a number of key finance and strategy leadership positions across Gilead, GlaxoSmithKline and AstraZeneca, where she spearheaded transformative initiatives in corporate development, finance transformation, and global commercial strategy.
Her tenure in financial excellence and global expansion includes successfully delivering several strategic growth initiatives across highly competitive and complex markets in Europe and US. With an early career as a scientist in oncology research, Stefanie offers a unique perspective, bridging scientific and financial disciplines in support of life sciences innovation.
Nancy Stahulak
Vice President U.S. Sales & Global Marketing
Nancy is a strategic, customer-focused marketing leader with a proven track record for driving top-line growth and long-term market sustainability.
Before NATROX® Wound Care, Nancy worked at Medela, the world’s leading medical vacuum technology manufacturer based in Switzerland. During her tenure there, Nancy was the Director of Marketing for the Healthcare Division responsible for marketing strategy, sales enablement, and clinical solutions for Negative Pressure Wound Therapy (NPWT), cardiothoracic surgery, and PVS Airway products. Her work experience also includes marketing executive and leadership positions at GE Healthcare Ultrasound, GE Capital, GE Medical Protective, and hospital networks including Advocate Health and Loyola Health Systems.
Nancy brings her experience from larger organizations to help scale the business globally. She has a solid understanding of the challenges facing the wound care industry and a deep understanding of our customers.
Nick Howard
Global Business Unit Director
After successfully commercializing NATROX® O2 in the UK market, Nick’s current focus is driving the strategic direction of the NATROX® Wound Care brand by supporting its global market opportunities and the development of new technologies.
Before joining the company, Nick was Global Category Director for Acelity, managing several market-leading global wound care brands, growing them to a revenue of +$120M.
His career in healthcare spans 24 years and includes roles in the NHS, SCA Hygiene Products (Essity), and healthcare communications, plus international sales & marketing positions for Mölnlycke Healthcare and ConvaTec, leading medical solutions companies.
Sandy Fliri-Marx
Human Resources Director
Sandy brings over 20 years of HR experience, with more than half her career in leading Life Sciences firms such as Amgen, Abcam, and Novartis. She has a strong interest in health care on both a professional and personal level, serving as a volunteer at The Hospice Biographers, and supporting students move from education into employment in Life Sciences with Form the Future.
Sandy has developed successful HR strategies for organizations of varying sizes with locations across the globe. Her role is pivotal for Inotec’s expansion. She is responsible for developing HR strategies and systems, managing employee relations, and recruiting and onboarding staff.
Lamine Guendil
General Manager Asia
Lamine manages Inotec Asia, our Southeast Asian sales headquarters based in Kuala Lumpur, Malaysia. His team’s focus is to provide innovative therapies for people suffering chronic wounds across the region.
Originally serving as a NATROX® distributor, after Lamine witnessed the positive healing impact our products had on wounds first-hand, he later decided to join the Inotec family. Lamine brings an intense passion for sales, a strong customer-focus, and a creative approach.
David Fernández
Sales Director EMEA & LATAM
David brings over 14 years of experience in medical devices across a range of areas including dental, respiratory, and diagnostic. Although his main experience is in sales, he has also held positions in product marketing, giving him a well-rounded understanding of customer needs.
With a proven track record of setting up distributor networks in the medical device field across EMEA, David plays a pivotal role in maximizing business opportunities with a strong focus to the EMEA and LATAM regions.
Dr. Windy Cole, DPM, CWSP, FAPWH
Global Medical Affairs Director
Dr. Cole has been a practicing physician in wound care for over 22 years. She is an adjunct professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. Board-certified by the American Board of Foot and Ankle Surgery and the American Board of Wound Management, Dr. Cole has published numerous peer-reviewed and industry articles and is a sought-after speaker worldwide. She is also a feature writer for Podiatry Management, Today’s Wound Clinic, and a contributing writer for Podiatry Today.
She has been a dedicated wound care advocate for two decades with interests in medical education, diabetic foot care, wound care, limb salvage, and clinical research. Her passion for helping others has led her to participate in humanitarian efforts including a medical mission to Jordan in 2018 to aid the large Syrian refugee population seeking asylum from civil war. At the forefront of wound research, she was the 2020 World Union of Wound Healing Silver Medal Award recipient for her work in Technology-Driven Research and the 2022 recipient of the Kaplan-Kanat Memorial Lecture Award.
She holds a bachelor’s degree in biology from the University of Cincinnati where she graduated summa cum laude. She is also an honor graduate of Kent State University College of Podiatric Medicine.
Michael Clancy
Non-Executive Director
Michael Clancy has 35 years’ experience in marketing, sales and general management within European medical devices with specialist knowledge and experience within the medical beds, pressure redistribution and wound care sectors. He is currently non-executive director at Medstrom Ltd and Inotec AMD Limited.
Pierre Socha
Non-Executive Director
Pierre Socha is an early-stage technology investor with Amadeus Capital Partners. He invests in digital health, medical technologies, autonomous systems, augmented reality, cyber security and artificial intelligence. He currently sits on the boards of Doctify, Repositive, Lumeon, PhoreMost and Congenica.
Craig Kennedy
Advisor
Craig has deep insight into the wound care market combined with a proven track record of building businesses. He served as CEO of MolecuLight, a Canadian wound care start-up that developed and launched an imaging device capable of detecting bacteria in wounds.
He also served as VP of Business Development and Strategy for UK-based Systagenix, an established provider of advanced wound care (AWC) products. When the firm was purchased by Acelity, a global AWC company, Craig was a key player facilitating the acquisition.
Craig was named a 10 Best Inspiring CEO of 2020 for his global approach, commercial credibility, customer focus, and clear communication across all stakeholder groups.
Your opportunity to advance wound care
Let’s do big things.
Together we can change wound
care for the better.
